TechNavio reports strong growth is expected to continue in the international medical imaging reagents market, reaching a compound annual growth rate of 7.95% from 2012 through 2016, driven by the increasing demand for radiopharmaceuticals and the aging population. However, the report noted that imaging reimbursement remains a concern. Top pharmaceutical companies including GE Healthcare, Covidien, Bracco and Lantheus Medical Imaging will continue to be major players, according to the report.

Related Summaries